Cipla appoints Peter Lankau as an Independent Director on its Board
Lankau has over 30 years of management experience in developing and commercialising pharma products
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
110 students graduate from Biocon Academy
The convocation ceremony was held recently in Bengaluru
Shripad Naik inaugurates international conference on ‘Yoga for Diabetes’
The three-day conference will draw up a road map to be adopted for the control of diabetes through Yoga
Sun Pharma successfully conducts Phase-3 clinical trial for Seciera
Seciera, developed by Ocular Technologies, will be used for the treatment of dry eye
Jubilant Life signs deals for diagnostic product supply
The products will be supplied over 39 months effective January 2017
ACG’s Pithampur facility receives Gold Rating by IGBC LEED-India
The facility implemented various measures such as infrastructure for rain water harvesting, usage of recyclable material during…
Panacea Biotec raises supply of life saving drug
The drug is used for the treatment of Wilson's disease, a genetic disorder in which copper builds up in the body
Suven Life receives patent for neuro-degenerative drug
The patents are valid until 2032 and 2025
Natco Pharma launches first generic version of hepatitis C tabs in Nepal
Natco will market Sofosbuvir 400mg/Velpatasvir 100mg under the brand name VELPANAT
Natco Pharma has launched the first generic…
Lupin receives approval for generic Livalo tablets
The tablets are indicated as an adjunctive therapy to diet to reduce elevated total cholesterol
Zydus acquires six brands from MSD
Adds brands in the men’s health, women’s health, cardiovascular and wound management segments to its strong brand portfolio
Zydus…
Generic Respiratory Drug Development Symposium to be held in Mumbai
The symposium will take place on January 19 and 20, 2017
Jubilant Life Sciences announces price hike of drugs
Select products will see a price hike of up to 15 per cent
Glenmark gets US FDA nod for leukemia treatment drug
The approved product is a generic version of Vesanoid capsules, 10 mg, of Hoffmann La Roche
Mylan and Biocon’s proposed biosimilar trastuzumab phase 3 data published in JAMA
Heritage study results demonstrate equivalent overall response rate for MYL-1401O in comparison to branded trastuzumab
Panacea Biotec launches tetravalent vaccine easyfour-TT
The vaccine will protect infants from diphtheria, tetanus, whooping cough and Hib-Meningitis in India
Lupin gets US FDA nod for hypertension drug
Olmesartan medoximil tablets are used to treat high blood pressure in the US market
Cipla’s flagship product Sereflo receives approval from UK MHRA
Sereflo, 25 mcg/125 mcg & 25 mcg/250 mcg are generic equivalent to GlaxoSmithKline’s Seretide Inhalers and are indicated for…
Sun Pharma to acquire Odomzo from Novartis
Odomzo has marketing approval in over 30 countries globally including US, Europe and Australia
MoHFW, NCC-PvPI to launch Pv training programme
First course from Jan 16-25, last date to apply extended to December 30